Trial
NCT00665457
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
filgrastim
Why stopped
study drug was removed from the market and low enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-13